Breed Reply Invests in Fast Growth Predictive Analytics Company
Breed Reply , Reply Group’s operational investor for early stage businesses in the Internet of Things (IoT), has boosted its portfolio of fast-growth, innovative businesses, with its 18th investment in a leading company in predictive analytics.
We Predict works primarily with global car manufacturers and suppliers, predicting warranty failure rates and costs. The firm’s complex analytics software uses mathematical and statistical principles, supported by data techniques, to provide valuable information to save customers time and money.
We Predict, with offices in the US and UK, also works in the health sector, delivering predictive analytics to help commissioning decision making in the NHS.
Breed Reply is both funding and providing hands-on support in developing and growing the company across business functions, from general management to sales, marketing and technology. Finance Wales Group, one of the UK’s largest regional SME investment companies, has joined this investment round lead by Breed Reply.
Emanuele Angelidis, CEO of Breed Reply , says: “We’re delighted to welcome on board We Predict. Predictive analytics is a game-changing innovation in operations and financial risk management. We Predict’s solution is already enabling automotive manufacturers to reduce warranty costs and improve efficiency and is applicable to many other industries.
We are incredibly impressed with the strong track record and experienced management team of We Predict that have enabled its success so far. We are confident that with our help, we can contribute to the new heights they will achieve. ”
Richard Thompson, of Finance Wales Group, adds: “It’s great to be working with Breed Reply again in funding an outstanding company like We Predict. ”
James Davies, Director at We Predict , comments: “This is a terrific opportunity for us to scale the business alongside a committed investor which goes above and beyond just offering capital to support our growth plans. Our teams are looking forward to working closely with Breed Reply to take us to the next stage .”
Breed Reply, Reply's active operational investor, funds and supports the development of early-stage companies in the Internet of Things (IoT) in Europe and the USA. Based in London, with operational offices in Germany and Italy, Breed Reply supports entrepreneurs and young talent by quickly bringing new ideas to the market. This is done via three fundamental services: funding at early-stage level; active operational involvement with significant know how transfer of business, managerial and technological expertise; and go-to market support through the extensive Reply network. Breed Reply focuses on Health, Fitness & Wellness, Smart Building & Cities, Security, Industrial IoT, Big Data, Platforms, Drones.
We Predict has grown rapidly by helping global blue chip customers, supported through its worldwide partner channels, across automotive, manufacturing and healthcare. The company is based in the UK and uses modern working practices to draw upon a global talent pool and best-in-class resources. In this way, We Predict is able to assist any customer or partner worldwide to address critical business challenges. The company’s team of mathematicians, statisticians and computer scientists use the latest tools and techniques to deliver results with greater depth, quicker timeframe and more meaningful metrics that can be easily understood by everyone.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
CA-VISA-INC.20.9.2017 09:03 | pressemeddelelse
Visa Announces Team Visa Roster for the Upcoming Olympic and Paralympic Winter Games
WA-BROOKS-RUNNING20.9.2017 06:03 | pressemeddelelse
Brooks Levitate with DNA AMP Delivers Infinite Energy
IPSEN19.9.2017 18:03 | pressemeddelelse
Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy
CA-PATIENT-SAFETY-MVMNT19.9.2017 17:02 | pressemeddelelse
6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England
MA-VERTEX19.9.2017 16:52 | pressemeddelelse
Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference
DELTICOM-AG19.9.2017 15:59 | pressemeddelelse
Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum